News

Anyone who follows aviation, as this editor does, is eager to learn about the features and capabilities of new aircraft when they get introduced, particularly if there is something groundbreaking about the design. But most pilots would not be so eager to get behind the controls and fly one of those new planes before has undergone testing. That is the role of a test pilot. It doesn’t happen often, b…

Subsense, Inc., the Palo Alto, CA manufacturer of brain neuromodulation systems, is not the only startup to target the market for brain-computer interfaces. But the company’s novel nanoparticle-based noninvasive technology stands to set the firm apart from the myriad others entering this space. The company emerged from stealth mode in February of this year, and earlier this month, hosted an open house at its California headquarters.

Since the early days of the neurotechnology industry, neural engineers have sought to devise networks of implantable neurostimulators that can deliver stimulation to different anatomical targets and communicate with other devices on the network. Twenty years ago, researchers at the Alfred Mann Foundation presented the concept of a networked neuroprosthesis consisting of multiple injectable BION stimulators.

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several panelists and presenters have been added to the agenda for the 25th annual Neurotech Leaders Forum, which take place November 5-6, 2025 in San Francisco. New speakers include Murthy Simhabhatla, CEO of SetPoint Medical, Ryan Field, CEO of Kernel, Andreas Forland, CEO of Cognixion, and Oliver Armitage, newly appointed vice president of Axoft.

According to our 2024 Market Report on Bioelectronic Medicine, OAB is the leading segment in the bioelectronic medicine market and is poised for continued growth in coming years due to an aging population, chronic stress, and growing patient awareness of neuromodulation therapies. In the OAB market, implantable SNS devices hold the lion’s share, while wearable devices for percutaneous and transcutaneous tibial nerve stimulation remain on the margins, as we reported in our December 2024 issue.

The Cleveland Neurodesign Entrepreneurs Workshop, a novel program dedicated to cultivating entrepreneurship in neurotechnology, reached a major milestone earlier this month when it welcomed its 200th student. Modeled on the Stanford Biodesign framework but tailored to the unique challenges of neurotech commercialization, CNEW continues to serve as a launchpad for the next generation of innovators.

By now, most professionals in the neuromodulation industry have become aware of some of the negative news reports and journal articles calling into question the value of spinal cord stimulation for treating back pain. The SCS industry has fought back on a number of fronts and continues to offer product enhancements and sponsor clinical trials that can produce the scientific evidence necessary to convince patients, payers, and regulators that the therapy is effective and appropriate.

In recent years, neuroengineers have devised a number of new modalities for interfacing with the nervous system. Among these are optical stimulation, vibrational stimulation, and optogenetics. A newer and perhaps more promising technology is sonogenetics. Sonogenetics, the use of focused ultrasound to control cells that have been made ultrasound-responsive via gene delivery, is moving from compelling papers to a potential platform strategy.

OSA is a serious health condition affecting an estimated 23 million people in the U.S. If left untreated, it significantly increases the risk of cardiovascular and neurological diseases. The standard treatment is Continuous Positive Airway Pressure, but its effectiveness is limited , with only about 40% of users sticking with the therapy long-term. For patients who cannot tolerate CPAP, surgical options are available.

The 7th Annual Meeting of the American Society of Pain and Neuroscience, held July 16–20, 2025, at the Fontainebleau Miami Beach, brought together more than 4,100 attendees—roughly half healthcare professionals. As ASPN continues to grow in influence and reach, this year’s event emphasized its core mission: improving education, elevating young professionals, and embracing innovation through disruption.